Cutaneous leishmaniasis (CL) caused by Leishmania protozoa and transmitted through infected sandfly bites, poses a significant public health burden in Morocco. Our research aims to retrospectively assess spatio-temporal patterns of CL in the most densely populated region of the country, Casablanca - Settat, during a period of 14 years (2009 - 2022). We investigate epidemiological trends, seasonal fluctuations and climatic factors influence on CL prevalence and predict cases in the region's most important CL focus. Using Geographic Information Systems (GIS) and statistical methods, we analyzed CL data obtained from the Moroccan Ministry of Health and Social Protection with demographic information and climate related parameters. Four machine learning prediction models for CL cases in the El Brouj focus were compared and their performance was evaluated. Our results revealed a steady increase in CL cases until 2019, followed by a significant surge, with Leishmania tropica identified as the causative agent for all documented cases. The incidence rates varied among demographic groups, with higher rates observed in females and children aged 5 to 14. Seasonal analysis indicated a notable increase in cases during spring. Spatial distribution analysis identified El Brouj as the sole endemic CL focus and the highest hotspot in the area, underscoring the necessity of targeted interventions in this location. Furthermore, Spearman correlation analysis revealed a significant association between CL cases and low temperature and precipitation, emphasizing climate variables role in disease incidence. Prediction modeling for future CL cases in El Brouj focus was assessed with six different models and Linear Regression was the most suitable. This retrospective study provides crucial insights into CL epidemiology in the Casablanca-Settat region, highlighting the need for implementing a coordinated approach tailored to the region that could help curb the spread of CL in Settat province, given the predictive model's outlook on future CL trends in this area.

The authors have declared no competing interest.

The author(s) received no specific funding for this work.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The approval for this study was obtained from the Ministry of Health and Social Welfare in Morocco. Since data were collected during routine active surveillance, no parents were interviewed and no patients' names were recorded. Thus, ethical approval was not required for this study. Fully anonymized data were accessed on November 21st 2023.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors